RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Novella Clinical Inc. announced today that it has appointed Ron Kershner to the position of Global Head of Clinical Reporting, where he will have executive management oversight for all Biostatistics and SAS programming activities within Novella Clinical. Dr. Kershner will work closely with existing Clinical Reporting management across all U.S. operations, including the Boulder, Columbus, and Research Triangle Park offices, to ensure Novella has the resources and processes in place to meet the ongoing needs of clients.
Ron Kershner received his Ph.D. in Biostatistics from Cornell University and has over 25 years experience in all operational aspects of clinical trial planning, execution and delivery within the pharmaceutical, biotechnology and contract research industries. For the past 13 years, Ron has worked in several CROs including 7 years at Inveresk Research where he served as Vice President, Medical Data Sciences and provided hands-on executive level management of the day to day global operations of data management and biostatistics. Prior to Inveresk, he held various positions at Fujisawa, Centocor and Quintiles.
"Ron brings to Novella a wealth of experience within the CRO industry at various levels of management, and we are extremely fortunate to have him join our Clinical Reporting group as well as our executive management team," says Stan Patterson, Vice President, Data Operations. "He has worked across all study phases and indications, most notably oncology, CNS, and cardiovascular, and has extensive experience with the FDA and NDA submissions – both of which are very important to our client base."
"I am pleased to be part of the Novella team and look forward to bringing value to client relationships, and to also work with the Novella operational teams to meet and exceed client expectations," added Dr. Kershner.
About Novella Clinical
For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although our clinical experience is all-inclusive, our eClinical roots enable us to offer services that are specific to our clients’ needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report — we integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. Our focus on quality customer service is reflected in our certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008). For more information, visit www.novellaclinical.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6517753&lang=en